- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/861 - Adenoviral vectors
Patent holdings for IPC class C12N 15/861
Total number of patents in this class: 1716
10-year publication summary
|
71
|
115
|
88
|
108
|
120
|
131
|
113
|
103
|
95
|
19
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Trustees of the University of Pennsylvania | 4405 |
46 |
| The Regents of the University of California | 20473 |
34 |
| University of Massachusetts | 2286 |
30 |
| University of Florida Research Foundation, Inc. | 4134 |
27 |
| Janssen Vaccines & Prevention B.V. | 292 |
26 |
| The University of North Carolina at Chapel Hill | 2074 |
26 |
| Glaxosmithkline Biologicals S.A. | 1614 |
24 |
| Voyager Therapeutics, Inc. | 278 |
20 |
| The Salk Institute for Biological Studies | 451 |
19 |
| Mayo Foundation for Medical Education and Research | 3345 |
16 |
| GenVec, Inc. | 54 |
16 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3353 |
15 |
| Genethon | 257 |
14 |
| Oxford University Innovation Limited | 1617 |
14 |
| Washington University | 1687 |
14 |
| Cansino Biologics Inc. | 82 |
14 |
| Epicentrx, Inc. | 91 |
12 |
| Janssen Biotech, Inc. | 1656 |
12 |
| Universitat Autonoma de Barcelona | 333 |
12 |
| Adverum Biotechnologies, Inc. | 102 |
11 |
| Other owners | 1314 |